---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-030522"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2021-12-06T23:59:59+00:00"
generated_at: "2026-06-28T03:31:20.087768+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Matinas BioPharma appoints Thomas Hoover as Chief Business Officer; $412k salary, 850k options

## Summary
- Thomas Hoover, 52, appointed Chief Business Officer effective December 6, 2021.
- Initial base salary of $412,000 with target bonus up to 40% of base.
- Grant of options to purchase 850,000 shares under 2013 Equity Incentive Plan.
- Previously Chief Business Officer at Millendo Therapeutics (NASDAQ: TPST) and VP at Sunovion.
- Newly created role to lead business development, strategic planning, and licensing.

## SEC filing metadata
- accession: 0001493152-21-030522
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2021-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000149315221030522/0001493152-21-030522-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000149315221030522/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-030522
- JSON: https://secwatch.observer/filing/0001493152-21-030522.json
- Plain text: https://secwatch.observer/filing/0001493152-21-030522.txt

## Key facts
- Executive change
  Thomas Hoover was appointed as Chief Business Officer at Matinas BioPharma Holdings, Inc..
  - Action: appointed
  - Role: Chief Business Officer
  source text: On December 6, 2021, Matinas BioPharma Holdings, Inc. (the “Company” or “Matinas”) announced that Thomas Hoover, age 52, has been appointed as the Company’s Chief Business Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1582554/000149315221030522/0001493152-21-030522-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.